Loading…
Lisata Therapeutics, Inc. is projected to rise to $3.44 by 2027, a +5% move from its current price of $3.27. LSTA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $3.20 | $3.27 | $3.34 | -0.02% |
| Jul 15 | $3.18 | $3.27 | $3.36 | -0.04% |
| Jul 16 | $3.16 | $3.27 | $3.38 | -0.06% |
| Jul 17 | $3.14 | $3.27 | $3.40 | -0.08% |
| Jul 18 | $3.12 | $3.27 | $3.42 | -0.10% |
| Jul 19 | $3.11 | $3.27 | $3.43 | -0.12% |
| Jul 20 | $3.10 | $3.27 | $3.44 | -0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.10 | $3.27 | $3.44 | -0.14% |
| Week 2 | $3.03 | $3.26 | $3.52 | -0.27% |
| Week 3 | $2.97 | $3.26 | $3.57 | -0.41% |
| Week 4 | $2.92 | $3.25 | $3.62 | -0.55% |
| Week 5 | $2.88 | $3.25 | $3.66 | -0.68% |
| Week 6 | $2.85 | $3.24 | $3.69 | -0.82% |
| Week 7 | $2.81 | $3.24 | $3.73 | -0.96% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases.
Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens.
The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Lisata Therapeutics, Inc. is a healthcare company focused on developing therapies for solid tumors and related diseases.
Its current price is $3.21 and its market capitalization stands at $29.23M, with a rank of 4764.
The stock’s price outlook reflects a long-term bullish tilt suggested by the year-by-year forecast, which shows gradual gains from 2026 through 2050 alongside rising average prices and bullish sentiment in later years.
The forecast structure indicates a path of rising averages from 2026 through 2050, with the average price progressing from $3.21 in 2026 to $15.86 in 2050 (and higher potential in the max values), signaling an upward trajectory over the multi-year horizon.
A major floor 13.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.8% away) — a key level to hold.
The nearest ceiling, 10.4% above — a clean break opens room to run.
A major ceiling 54.1% above — clearing it would confirm fresh momentum.
Key LSTA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LSTA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.27 | Buy | $3.27 | Sell |
| MA 10 | $3.32 | Sell | $3.31 | Sell |
| MA 20 | $3.40 | Sell | $3.35 | Sell |
| MA 50 | $3.33 | Sell | $3.46 | Sell |
| MA 100 | $3.90 | Sell | $3.52 | Sell |
| MA 200 | $3.26 | Buy | $3.36 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.21 | Neutral |
| Stoch RSI (14) | 36.71 | Neutral |
| CCI (20) | -104.07 | Sell |
| Williams %R (14) | -76.92 | Info |
| MACD (12,26,9) | -0.02 | Sell |
| ROC (12) | -5.76 | Sell |
| Bollinger %B (20,2) | 0.17 | Neutral |
| Stochastic %K (14) | 23.08 | Neutral |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | -0.12 | Sell |
| Ultimate (7,14,28) | 29.99 | Buy |
| Momentum (10) | -0.11 | Sell |
| Aroon Osc (25) | -72.00 | Sell |
| Hull MA (9) | 3.21 | Buy |
| ADX (14) | 13.05 | Neutral |
| ATR (14) | 0.05 | Info |
The 30-day technical picture is NEUTRAL.
RSI14 is 40. SMA50 is $3.32 and SMA200 is $3.25. Support is $3.20 and resistance is $3.61. The thirty-day price range runs from $2.79 to $3.69, reflecting modest volatility over the period. Annualized volatility stands at 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.93 | $3.27 | $4.08 | 0% | Neutral | |
| $2.80 | $3.44 | $4.41 | +5% | Neutral | |
| $3.21 | $4.01 | $5.30 | +23% | Bullish | |
| $3.55 | $4.51 | $6.09 | +38% | Bullish | |
| $3.69 | $4.76 | $6.56 | +46% | Bullish | |
| $4.02 | $5.25 | $7.35 | +61% | Bullish | |
| $3.84 | $5.07 | $7.20 | +55% | Bullish | |
| $3.83 | $5.12 | $7.38 | +57% | Bullish | |
| $4.38 | $5.92 | $8.63 | +81% | Bullish | |
| $4.82 | $6.58 | $9.70 | +101% | Bullish | |
| $5.85 | $8.36 | $12.95 | +156% | Bullish | |
| $10.85 | $16.74 | $27.88 | +412% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.93 | $3.27 | $3.92 | +0.00% |
| August 2026 | $2.77 | $3.25 | $3.90 | -0.55% |
| September 2026 | $2.73 | $3.21 | $3.88 | -1.23% |
| October 2026 | $2.79 | $3.30 | $4.02 | +2.84% |
| November 2026 | $2.82 | $3.35 | $4.10 | +1.55% |
| December 2026 | $2.78 | $3.32 | $4.08 | -1.16% |
Click any year to see its month-by-month LSTA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The LSTA price prediction for 2026 points to an average of $3.27 (low $1.93, high $4.08) — a potential gain of 0% on today's $3.27. A consolidation phase looks the most probable path here.
In 2027, LSTA is projected to trade between $2.80 and $4.41, averaging $3.44 — a potential gain of +5% from today's $3.27. That is up +5% on the projected 2026 average. Price action looks broadly range-bound.
Lisata Therapeutics, Inc.'s 2028 outlook centres on $4.01, within a $3.21 to $5.30 range. That is up +17% on the projected 2027 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, LSTA could reach as high as $6.09, with a base case around $4.51 and support toward $3.55 — roughly +38% from $3.27. Momentum favours further upside here.
Expect LSTA to range from $3.69 to $6.56 through 2030. The $4.76 average target implies a +46% move from current prices. That is up +6% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The LSTA price prediction for 2031 points to an average of $5.25 (low $4.02, high $7.35) — a potential gain of +61% on today's $3.27. Momentum favours further upside here.
In 2032, LSTA is projected to trade between $3.84 and $7.20, averaging $5.07 — a potential gain of +55% from today's $3.27. That is -3% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
Lisata Therapeutics, Inc.'s 2033 outlook centres on $5.12, within a $3.83 to $7.38 range. That is up +1% on the projected 2032 average. That marks a +57% change versus current levels. Momentum favours further upside here.
By 2034, LSTA could reach as high as $8.63, with a base case around $5.92 and support toward $4.38 — roughly +81% from $3.27. Buyers look set to stay in control over this stretch.
Expect LSTA to range from $4.82 to $9.70 through 2035. The $6.58 average target implies a +101% move from current prices. That is up +11% on the projected 2034 average. Momentum favours further upside here.
The LSTA price prediction for 2040 points to an average of $8.36 (low $5.85, high $12.95) — a potential gain of +156% on today's $3.27. Buyers look set to stay in control over this stretch.
In 2050, LSTA is projected to trade between $10.85 and $27.88, averaging $16.74 — a potential gain of +412% from today's $3.27. That is up +100% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in LSTA today (≈ 305.810398 LSTA) could be worth
$5,117.83
+$4,117.83 (+412%) by 2050 · US Dollar
Based on the average projected LSTA price of $16.74 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LSTAwould be worth at today's price.
$1,000 invested in LSTA on Jul 10, 2025 (≈ 364.963502 LSTA) would be worth
$1,193.43
+$193.43 (+19.3%) today · 1.19× · US Dollar
Based on a LSTA entry price of $2.74 vs. today's $3.27.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $3.33 | $981.98 | -1.8% |
| 1 month ago | $3.61 | $905.82 | -9.4% |
| 3 months ago | $5.01 | $652.69 | -34.7% |
| 6 months ago | $2.08 | $1,572.12 | +57.2% |
| 1 year ago | $2.74 | $1,193.43 | +19.3% |
| All time (5.0y) ago | $21.75 | $150.34 | -85.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LSTA forecast.
Our base-case forecast reaches $6.50 around 2035.
Implied market cap at $6.50: $59.19M
The multi-year forecast starts with a neutral stance in 2026, showing min $1.93, avg $3.21, max $4.01 and ROI 0. The sentiment for 2026 is NEUTRAL.
In 2027 the forecast moves to min $2.73, avg $3.36, max $4.34 with ROI 4.8 and sentiment NEUTRAL. In 2028 the average climbs to $3.89 with min $3.09 and max $5.17 and ROI 21.1, yielding a BULLISH sentiment.
From 2029 through 2033 the forecast remains BULLISH, with 2029 avg $4.36 (ROI 35.9), 2030 avg $4.62 (ROI 44), 2031 avg $5.06 (ROI 57.7), 2032 avg $4.88 (ROI 52), and 2033 avg $4.93 (ROI 53.7).
The ascent continues with 2034 avg $5.67 (ROI 76.5) and 2035 avg $6.28 (ROI 95.8), followed by 2040 avg $7.94 (ROI 147.4). The long-range view reaches 2050 with avg $15.86 (ROI 394.2). All years show a BULLISH sentiment except 2026–2027 which are NEUTRAL.
These are estimates, not guarantees, and reflect the projected directional path of prices over the horizon.
Tap a question to reveal the answer.
The forecast shows an average price of $4.62, with a min of $3.56 and a max of $6.42, ROI 44, and sentiment BULLISH.
The 2026 forecast is NEUTRAL with avg $3.21 and ROI 0. From 2028 onward, the forecast turns BULLISH with rising averages (e.g., $3.89 in 2028, $4.36 in 2029, $4.62 in 2030, up to $15.86 by 2050) and ROI climbing to 147.4 by 2040 and 394.2 by 2050.
Yes. The forecast shows 2031 with avg $5.06; 2034 with avg $5.67; and 2035 with avg $6.28, with corresponding min and max values indicating potential movement above $5 in the mid-2020s horizon.
The 30-day technical picture is NEUTRAL. RSI14 is 40. SMA50 is $3.32 and SMA200 is $3.25. Support is $3.20 and resistance is $3.61. The 30-day range is $2.79 to $3.69, and annualized volatility is 40%.
Current price is $3.21 and market cap is $29.23M. The stock ranks 4764.
Lisata Therapeutics, Inc. Community Discussion
0Share your Lisata Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.